cholera toxin B protein (CTB)
Vibrio cholerae
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Protein homooligomer Homooligomer Protein × 5 PDB declaration: pentameric(5) Consistent with protein copy count | Chain D; UniProt 22–124 Chain E; UniProt 22–124 Chain F; UniProt 22–124 Chain G; UniProt 22–124 Chain H; UniProt 22–124 | Not recorded | BV2 1,3-BIS-([3-(4-{3-[3-NITRO-5-(GALACTOPYRANOSYLOXY)-BENZOYLAMINO]-PROPYL}-PIPERAZIN-1-YL)-PROPYL-AMINO]-CARBONYLOXY)-2-AMINO-PROPANE × 5 TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1 P6G HEXAETHYLENE GLYCOL × 1 | X-RAY DIFFRACTION X-ray crystallization conditions:VAPOR DIFFUSION, SITTING DROP;pH 7.5;298 K;38% PEG 300, 50 mM NaCl, 100 mM Tris-HCl, and 2.3mM BV2, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K | Resolution 1.44 Å R-free 0.184 |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 1RD9 | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 1CHP SURPRISING LEADS FOR A CHOLERA TOXIN RECEPTOR BINDING ANTAGONIST; CRYSTALLOGRAPHIC STUDIES OF CTB MUTANTS Deposited 1995-02-15 | Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric |
Chain D
22–124(103 aa)
Chain E
22–124(103 aa)
Chain F
22–124(103 aa)
Chain G
22–124(103 aa)
Chain H
22–124(103 aa)
|
Mutation:G33D Mutation:G33D Mutation:G33D Mutation:G33D Mutation:G33D | CL CHLORIDE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.5;pH 7.5
|
Resolution 2.00 Å |
| 1CHQ SURPRISING LEADS FOR A CHOLERA TOXIN RECEPTOR BINDING ANTAGONIST; CRYSTALLOGRAPHIC STUDIES OF CTB MUTANTS Deposited 1995-02-15 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric |
Chain D
29–131(103 aa)
Chain E
29–131(103 aa)
Chain F
29–131(103 aa)
Chain G
29–131(103 aa)
Chain H
29–131(103 aa)
|
Mutation:R35D Mutation:R35D Mutation:R35D Mutation:R35D Mutation:R35D | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.4;pH 6.4
|
Resolution 2.10 Å |
| 1CT1 CHOLERA TOXIN B-PENTAMER MUTANT G33R BOUND TO RECEPTOR PENTASACCHARIDE Deposited 1997-06-03 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Homooligomer;Protein × 5 PDB declaration: pentameric |
Chain D
22–124(103 aa)
Fragment:B-PENTAMER
Chain E
22–124(103 aa)
Fragment:B-PENTAMER
Chain F
22–124(103 aa)
Fragment:B-PENTAMER
Chain G
22–124(103 aa)
Fragment:B-PENTAMER
Chain H
22–124(103 aa)
Fragment:B-PENTAMER
|
Mutation:G33R Mutation:G33R Mutation:G33R Mutation:G33R Mutation:G33R | CL CHLORIDE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
PROTEIN, 20 MM TRIS, 1 MM GM1-OS, PH 7.5 200 MM MGCL2, 100 MM CACODYLATE, 19% PEG 1000, 0.2% AGAROSE, PH 7.2
|
Resolution 2.30 Å R-free 0.250 |
| 1FGB TOXIN Deposited 1996-02-21 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric |
Chain D
22–124(103 aa)
Chain E
22–124(103 aa)
Chain F
22–124(103 aa)
Chain G
22–124(103 aa)
Chain H
22–124(103 aa)
|
Not recorded | No recorded non-water small molecule | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.40 Å |
| 1G8Z HIS57ALA MUTANT OF CHOLERA TOXIN B-PENATMER Deposited 2000-11-21 | Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric |
Chain D
22–124(103 aa)
Chain E
22–124(103 aa)
Chain F
22–124(103 aa)
Chain G
22–124(103 aa)
Chain H
22–124(103 aa)
|
Mutation:H57A Mutation:H57A Mutation:H57A Mutation:H57A Mutation:H57A | GAL beta-D-galactopyranose × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.4;298 K;PEG 5000, NaCl, Tris HCl, galactose, pH 8.4, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.00 Å R-free 0.239 |
| 1JR0 CHOLERA TOXIN B-PENTAMER WITH LIGAND BMSC-0011 Deposited 2001-08-09 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric |
Chain D
22–124(103 aa)
Chain E
22–124(103 aa)
Chain F
22–124(103 aa)
Chain G
22–124(103 aa)
Chain H
22–124(103 aa)
|
Not recorded | A24 (3-NITRO-5-(2-MORPHOLIN-4-YL-ETHYLAMINOCARBONYL)PHENYL)-GALACTOPYRANOSIDE × 5 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;PEG 3000, NaCl, MgCl2, Tris HCl, pH 7.5, VAPOR DIFFUSION, SITTING DROP
|
Resolution 1.30 Å R-free 0.183 |
| 1JR0 CHOLERA TOXIN B-PENTAMER WITH LIGAND BMSC-0011 Deposited 2001-08-09 | Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 10 PDB declaration: decameric |
Chain D
22–124(103 aa)
Chain E
22–124(103 aa)
Chain F
22–124(103 aa)
Chain G
22–124(103 aa)
Chain H
22–124(103 aa)
|
Not recorded | A24 (3-NITRO-5-(2-MORPHOLIN-4-YL-ETHYLAMINOCARBONYL)PHENYL)-GALACTOPYRANOSIDE × 10 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;PEG 3000, NaCl, MgCl2, Tris HCl, pH 7.5, VAPOR DIFFUSION, SITTING DROP
|
Resolution 1.30 Å R-free 0.183 |
| 1RCV Cholera Toxin B-Pentamer Complexed With Bivalent Nitrophenol-Galactoside Ligand BV1 Deposited 2003-11-04 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric |
Chain D
22–124(103 aa)
Chain E
22–124(103 aa)
Chain F
22–124(103 aa)
Chain G
22–124(103 aa)
Chain H
22–124(103 aa)
|
Not recorded | BV1 [3-(4-{3-[3-NITRO-5-(GALACTOPYRANOSYLOXY)-BENZOYLAMINO]-PROPYL}-PIPERAZIN-1-YL)-PROPYLAMINO] -2-(3-{4-[3-(3-NITRO-5-[GALACTOPYRANOSYLOXY]-BENZOYLAMINO)-PROPYL]-PIPERAZIN-1-YL} -PROPYL-AMINO)-3,4-DIOXO-CYCLOBUTENE × 5 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;298 K;30% PEG 300, 50 mM NaCl, 100 mM Tris-HCl, and 2.3mM BV1, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K
|
Resolution 1.60 Å R-free 0.193 |
| 1RDP Cholera Toxin B-Pentamer Complexed With Bivalent Nitrophenol-Galactoside Ligand BV3 Deposited 2003-11-05 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric |
Chain D
22–124(103 aa)
Chain E
22–124(103 aa)
Chain F
22–124(103 aa)
Chain G
22–124(103 aa)
Chain H
22–124(103 aa)
|
Not recorded | BV3 1,3-BIS-([[3-(4-{3-[3-NITRO-5-(GALACTOPYRANOSYLOXY)-BENZOYLAMINO]-PROPYL}-PIPERAZIN-1-YL)-PROPYLAMINO-3,4-DIOXO-CYCLOBU TENYL]-AMINO-ETHYL]-AMINO-CARBONYLOXY)-2-AMINO-PROPANE × 5 TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1 PGE TRIETHYLENE GLYCOL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;298 K;12% PEG 8000, 50 mM NaCl, 100 mM Tris-HCl, 20mM MgCl2, and 2.3mM BV3, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K
|
Resolution 1.35 Å R-free 0.171 |
| 1RF2 Cholera Toxin B-Pentamer Complexed With Bivalent Nitrophenol-Galactoside Ligand BV4 Deposited 2003-11-07 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric |
Chain D
22–124(103 aa)
Chain E
22–124(103 aa)
Chain F
22–124(103 aa)
Chain G
22–124(103 aa)
Chain H
22–124(103 aa)
|
Not recorded | BV4 1,3-BIS-([3-[3-[3-(4-{3-[3-NITRO-5-(GALACTOPYRANOSYLOXY)-BENZOYLAMINO]-PROPYL}-PIPERAZIN-1-YL)-PROPYLAMINO-3,4-DIOXO-CYCLOBUTENYL]-AMINO-PROPOXY-ETHOXY-ETHOXY]-PROPYL-]AMINO-CARBONYLOXY)-2-AMINO-PROPANE × 5 TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1 PGE TRIETHYLENE GLYCOL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;298 K;16% PEG 8000, 50 mM NaCl, 100 mM Tris-HCl, 20mM MgCl2, and 2.3mM BV4, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K
|
Resolution 1.35 Å R-free 0.174 |
| 1S5B Cholera holotoxin with an A-subunit Y30S mutation Form 3 Deposited 2004-01-20 | Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain D
22–124(103 aa)
Chain E
22–124(103 aa)
Chain F
22–124(103 aa)
Chain G
22–124(103 aa)
Chain H
22–124(103 aa)
|
Not recorded | NA SODIUM ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;298 K;PEG 2000mme, MES, kemptide, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 2.13 Å R-free 0.224 |
| 1S5C Cholera holotoxin with an A-subunit Y30S mutation, Crystal form 1 Deposited 2004-01-20 | Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain D
22–124(103 aa)
Chain E
22–124(103 aa)
Chain F
22–124(103 aa)
Chain G
22–124(103 aa)
Chain H
22–124(103 aa)
|
Not recorded | NA SODIUM ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;298 K;PEG 2000mme, MES, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 2.50 Å R-free 0.262 |
| 1S5D Cholera holotoxin with an A-subunit Y30S mutation, Crystal form 2 Deposited 2004-01-20 | Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain D
22–124(103 aa)
Chain E
22–124(103 aa)
Chain F
22–124(103 aa)
Chain G
22–124(103 aa)
Chain H
22–124(103 aa)
|
Not recorded | NA SODIUM ION × 1 GOL GLYCEROL × 5 GAL beta-D-galactopyranose × 5 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;298 K;PEG 3350, sodium citrate, galactose, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 1.75 Å R-free 0.191 |
| 1S5E Cholera holotoxin, Crystal form 1 Deposited 2004-01-20 | Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain D
22–124(103 aa)
Chain E
22–124(103 aa)
Chain F
22–124(103 aa)
Chain G
22–124(103 aa)
Chain H
22–124(103 aa)
|
Not recorded | NA SODIUM ION × 1 GAL beta-D-galactopyranose × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;298 K;PEG 3350, magnesium acetate, galactose, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 1.90 Å R-free 0.205 |
| 1S5E Cholera holotoxin, Crystal form 1 Deposited 2004-01-20 | Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain J
22–124(103 aa)
Chain K
22–124(103 aa)
Chain L
22–124(103 aa)
Chain M
22–124(103 aa)
Chain N
22–124(103 aa)
|
Not recorded | NA SODIUM ION × 1 GAL beta-D-galactopyranose × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;298 K;PEG 3350, magnesium acetate, galactose, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 1.90 Å R-free 0.205 |
| 1S5F Cholera holotoxin, Crystal form 2 Deposited 2004-01-20 | Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain D
22–124(103 aa)
Chain E
22–124(103 aa)
Chain F
22–124(103 aa)
Chain G
22–124(103 aa)
Chain H
22–124(103 aa)
|
Not recorded | NA SODIUM ION × 1 GAL beta-D-galactopyranose × 5 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;298 K;PEG 3350, lithium citrate, galactose, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 2.60 Å R-free 0.260 |
| 1S5F Cholera holotoxin, Crystal form 2 Deposited 2004-01-20 | Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain D
22–124(103 aa)
Chain E
22–124(103 aa)
Chain F
22–124(103 aa)
Chain G
22–124(103 aa)
Chain H
22–124(103 aa)
|
Not recorded | NA SODIUM ION × 1 GAL beta-D-galactopyranose × 5 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;298 K;PEG 3350, lithium citrate, galactose, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 2.60 Å R-free 0.260 |
| 1XTC CHOLERA TOXIN Deposited 1996-01-10 | Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 7 PDB declaration: heptameric |
Chain D
22–124(103 aa)
Chain E
22–124(103 aa)
Chain F
22–124(103 aa)
Chain G
22–124(103 aa)
Chain H
22–124(103 aa)
|
Not recorded | No recorded non-water small molecule | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.40 Å |
| 2CHB CHOLERA TOXIN B-PENTAMER COMPLEXED WITH GM1 PENTASACCHARIDE Deposited 1997-06-03 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Homooligomer;Protein × 5 PDB declaration: pentameric |
Chain D
22–124(103 aa)
Fragment:B-PENTAMER
Chain E
22–124(103 aa)
Fragment:B-PENTAMER
Chain F
22–124(103 aa)
Fragment:B-PENTAMER
Chain G
22–124(103 aa)
Fragment:B-PENTAMER
Chain H
22–124(103 aa)
Fragment:B-PENTAMER
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.5;200 MM MGCL2 100 MM CACODYLATE 5% PEG 1000 PH 7.5
|
Resolution 2.00 Å |
| 3CHB CHOLERA TOXIN B-PENTAMER COMPLEXED WITH GM1 PENTASACCHARIDE Deposited 1998-03-24 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Homooligomer;Protein × 5 PDB declaration: pentameric |
Chain D
1–124(124 aa)
Fragment:B-PENTAMER
Chain E
1–124(124 aa)
Fragment:B-PENTAMER
Chain F
1–124(124 aa)
Fragment:B-PENTAMER
Chain G
1–124(124 aa)
Fragment:B-PENTAMER
Chain H
1–124(124 aa)
Fragment:B-PENTAMER
|
Mutation:H94R Mutation:H94R Mutation:H94R Mutation:H94R Mutation:H94R | UNX UNKNOWN LIGAND × 5 MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;SITTING DROP, pH 7.0, vapor diffusion - sitting drop
|
Resolution 1.25 Å R-free 0.180 |
| 5ELC Cholera toxin El Tor B-pentamer in complex with Lewis-y Deposited 2015-11-04 | Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Homooligomer;Protein × 5 PDB declaration: pentameric |
Chain A
22–124(103 aa)
Chain B
22–124(103 aa)
Chain C
22–124(103 aa)
Chain D
22–124(103 aa)
Chain E
22–124(103 aa)
|
Not recorded | CA CALCIUM ION × 10 BCN BICINE × 10 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;293 K;0.1 M Bicine-Tris, 12.5% PEG1000, 12.5% PEG3350, 12.5% MPD, 0.03 M calcium chloride, 0.03 M magnesium chloride
|
Resolution 1.50 Å R-free 0.260 |
| 5ELC Cholera toxin El Tor B-pentamer in complex with Lewis-y Deposited 2015-11-04 | Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Other combination Homooligomer;Protein × 5 PDB declaration: pentameric |
Chain F
22–124(103 aa)
Chain G
22–124(103 aa)
Chain H
22–124(103 aa)
Chain I
22–124(103 aa)
Chain J
22–124(103 aa)
|
Not recorded | FUC alpha-L-fucopyranose × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;293 K;0.1 M Bicine-Tris, 12.5% PEG1000, 12.5% PEG3350, 12.5% MPD, 0.03 M calcium chloride, 0.03 M magnesium chloride
|
Resolution 1.50 Å R-free 0.260 |
| 5ELE Cholera toxin El Tor B-pentamer in complex with A Lewis-y Deposited 2015-11-04 | Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Homooligomer;Protein × 5 PDB declaration: pentameric |
Chain A
22–124(103 aa)
Chain B
22–124(103 aa)
Chain C
22–124(103 aa)
Chain D
22–124(103 aa)
Chain E
22–124(103 aa)
|
Not recorded | CA CALCIUM ION × 10 FUC alpha-L-fucopyranose × 1 BCN BICINE × 10 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;293 K;0.1 M Bicine-Tris, 9% PEG1000, 9% PEG3350, 9% MPD, 0.03 M calcium chloride, 0.03 M magnesium chloride
|
Resolution 1.60 Å R-free 0.226 |
| 5ELE Cholera toxin El Tor B-pentamer in complex with A Lewis-y Deposited 2015-11-04 | Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Other combination Homooligomer;Protein × 5 PDB declaration: pentameric |
Chain F
22–124(103 aa)
Chain G
22–124(103 aa)
Chain H
22–124(103 aa)
Chain I
22–124(103 aa)
Chain J
22–124(103 aa)
|
Not recorded | FUC alpha-L-fucopyranose × 3 1PE PENTAETHYLENE GLYCOL × 1 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;293 K;0.1 M Bicine-Tris, 9% PEG1000, 9% PEG3350, 9% MPD, 0.03 M calcium chloride, 0.03 M magnesium chloride
|
Resolution 1.60 Å R-free 0.226 |
| 5ELF Cholera toxin El Tor B-pentamer in complex with A-pentasaccharide Deposited 2015-11-04 | Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Homooligomer;Protein × 5 PDB declaration: pentameric |
Chain A
22–124(103 aa)
Chain B
22–124(103 aa)
Chain C
22–124(103 aa)
Chain D
22–124(103 aa)
Chain E
22–124(103 aa)
|
Not recorded | CA CALCIUM ION × 10 BCN BICINE × 10 FUC alpha-L-fucopyranose × 1 GLC alpha-D-glucopyranose × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;293 K;0.1 M Bicine-Tris, 9% PEG1000, 9% PEG3350, 9% MPD, 0.03 M calcium chloride, 0.03 M magnesium chloride. Microseeding.
|
Resolution 1.55 Å R-free 0.220 |
| 5ELF Cholera toxin El Tor B-pentamer in complex with A-pentasaccharide Deposited 2015-11-04 | Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Other combination Homooligomer;Protein × 5 PDB declaration: pentameric |
Chain F
22–124(103 aa)
Chain G
22–124(103 aa)
Chain H
22–124(103 aa)
Chain I
22–124(103 aa)
Chain J
22–124(103 aa)
|
Not recorded | FUC alpha-L-fucopyranose × 1 GLC alpha-D-glucopyranose × 1 PG4 TETRAETHYLENE GLYCOL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;293 K;0.1 M Bicine-Tris, 9% PEG1000, 9% PEG3350, 9% MPD, 0.03 M calcium chloride, 0.03 M magnesium chloride. Microseeding.
|
Resolution 1.55 Å R-free 0.220 |
| 5LZG Cholera toxin El Tor B-pentamer in complex with inhibitor PC262 Deposited 2016-09-29 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric |
Chain A
22–124(103 aa)
Chain B
22–124(103 aa)
Chain C
22–124(103 aa)
Chain D
22–124(103 aa)
Chain E
22–124(103 aa)
|
Not recorded | 7BN (2~{R},4~{S},5~{R},6~{R})-5-acetamido-2-[4-[3-[2-[(2~{S},3~{R},4~{R},5~{R},6~{R})-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]ethylamino]-3-oxidanylidene-propyl]-1,2,3-triazol-1-yl]-4-oxidanyl-6-[(1~{R},2~{R})-1,2,3-tris(oxidanyl)propyl]oxane-2-carboxylic acid × 5 TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1 IMD IMIDAZOLE × 2 PEG DI(HYDROXYETHYL)ETHER × 1 MRD (4R)-2-METHYLPENTANE-2,4-DIOL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M MES/Imidazole buffer, pH 6.5, 10% PEG 1000, 10 % PEG 3350, 10 % MPD, 0.03 M divalent cations
|
Resolution 1.13 Å R-free 0.198 |
| 5LZJ Cholera toxin El Tor B-pentamer in complex with inhibitor Laura237 Deposited 2016-09-29 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 5 PDB declaration: pentameric |
Chain A
22–124(103 aa)
Chain B
22–124(103 aa)
Chain C
22–124(103 aa)
Chain D
22–124(103 aa)
Chain E
22–124(103 aa)
|
Not recorded | SO4 SULFATE ION × 1 PEG DI(HYDROXYETHYL)ETHER × 2 PGE TRIETHYLENE GLYCOL × 2 7BT (~{Z})-~{N}-[2-[(2~{R},3~{R},4~{R},5~{R},6~{R})-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]ethyl]-3-(3,4,5-trimethoxyphenyl)prop-2-enamide × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.1M MES pH 6, 30% PEG 400, 3% PGA-LM
|
Resolution 1.20 Å R-free 0.228 |
| 8OXS Cholera holotoxin variant (chimera with E. coli heat-labile enterotoxin, 4 C-terminal substitutions) Deposited 2023-05-02 | Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain D
22–124(103 aa)
Chain E
22–124(103 aa)
Chain F
22–124(103 aa)
Chain G
22–124(103 aa)
Chain H
22–124(103 aa)
|
Not recorded | NA SODIUM ION × 1 GAL beta-D-galactopyranose × 6 GLA alpha-D-galactopyranose × 4 EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;293.15 K;Crystallization mix:
20% w/v PEG 6K
0.1 M HEPES pH 7.0
0.2 M NH4Cl
Protein storage buffer:
0.05 M Tris/HCl pH 7.5
0.2 M NaCl
0.05 M D-(+)-galactose
|
Resolution 1.60 Å R-free 0.224 |
| 8OXS Cholera holotoxin variant (chimera with E. coli heat-labile enterotoxin, 4 C-terminal substitutions) Deposited 2023-05-02 | Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain C
22–124(103 aa)
Chain I
22–124(103 aa)
Chain J
22–124(103 aa)
Chain K
22–124(103 aa)
Chain L
22–124(103 aa)
|
Not recorded | NA SODIUM ION × 1 GAL beta-D-galactopyranose × 4 GLA alpha-D-galactopyranose × 3 EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;293.15 K;Crystallization mix:
20% w/v PEG 6K
0.1 M HEPES pH 7.0
0.2 M NH4Cl
Protein storage buffer:
0.05 M Tris/HCl pH 7.5
0.2 M NaCl
0.05 M D-(+)-galactose
|
Resolution 1.60 Å R-free 0.224 |
| 8Q6I Cholera holotoxin variant (chimera with E. coli heat-labile enterotoxin, 1 C-terminal substitution) Deposited 2023-08-11 | Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain D
22–124(103 aa)
Chain E
22–124(103 aa)
Chain F
22–124(103 aa)
Chain G
22–124(103 aa)
Chain H
22–124(103 aa)
|
Not recorded | NA SODIUM ION × 2 GOL GLYCEROL × 11 PEG DI(HYDROXYETHYL)ETHER × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;293.15 K;Crystallization mix:
20% PEG6000
0.2 M lithium chloride
0.1 M Tris pH 8.0
Protein storage buffer:
0.05 M Tris/HCl pH 7.5
0.2 M NaCl
|
Resolution 1.60 Å R-free 0.222 |
| 8QRE Cholera holotoxin (wildtype) Deposited 2023-10-06 | Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain D
22–124(103 aa)
Chain E
22–124(103 aa)
Chain F
22–124(103 aa)
Chain G
22–124(103 aa)
Chain H
22–124(103 aa)
|
Not recorded | NA SODIUM ION × 2 GAL beta-D-galactopyranose × 6 GOL GLYCEROL × 7 ACT ACETATE ION × 2 PEG DI(HYDROXYETHYL)ETHER × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.4;293.15 K;Crystallization mix:
0.125 M Magnesium acetate
24% PEG 3350
300 mM galactose (in protein storage buffer)
Protein storage buffer:
50 mM Tris pH 7.4
200 mM NaCl
1 mM EDTA
3 mM sodium azide
|
Resolution 2.30 Å R-free 0.263 |
| 8QRE Cholera holotoxin (wildtype) Deposited 2023-10-06 | Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain C
22–124(103 aa)
Chain I
22–124(103 aa)
Chain J
22–124(103 aa)
Chain K
22–124(103 aa)
Chain L
22–124(103 aa)
|
Not recorded | NA SODIUM ION × 2 GAL beta-D-galactopyranose × 4 GOL GLYCEROL × 7 ACT ACETATE ION × 1 GLA alpha-D-galactopyranose × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.4;293.15 K;Crystallization mix:
0.125 M Magnesium acetate
24% PEG 3350
300 mM galactose (in protein storage buffer)
Protein storage buffer:
50 mM Tris pH 7.4
200 mM NaCl
1 mM EDTA
3 mM sodium azide
|
Resolution 2.30 Å R-free 0.263 |
| 9EWF Cholera toxin B subunit in complex with fluorinated GM1 Deposited 2024-04-03 | Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Homooligomer;Protein × 5 PDB declaration: pentameric |
Chain A
22–124(103 aa)
Chain B
22–124(103 aa)
Chain C
22–124(103 aa)
Chain I
22–124(103 aa)
Chain J
22–124(103 aa)
|
Not recorded | A1H7V (2R,3S,4S,5R,6R)-6-dodecoxy-5-fluoranyl-2-(hydroxymethyl)oxane-3,4-diol × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.1M MES/Imidazole pH 7.5, 0.03M MgCl2, 0.03M CaCl2, 16% PEG1000, 12% PEG3350 and 10% MPD
|
Resolution 2.10 Å R-free 0.221 |
| 9EWF Cholera toxin B subunit in complex with fluorinated GM1 Deposited 2024-04-03 | Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Other combination Homooligomer;Protein × 5 PDB declaration: pentameric |
Chain D
22–124(103 aa)
Chain E
22–124(103 aa)
Chain F
22–124(103 aa)
Chain G
22–124(103 aa)
Chain H
22–124(103 aa)
|
Not recorded | A1H7V (2R,3S,4S,5R,6R)-6-dodecoxy-5-fluoranyl-2-(hydroxymethyl)oxane-3,4-diol × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.1M MES/Imidazole pH 7.5, 0.03M MgCl2, 0.03M CaCl2, 16% PEG1000, 12% PEG3350 and 10% MPD
|
Resolution 2.10 Å R-free 0.221 |
26 other PDB entries and 35 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | CHTB_VIBCH |
| Isoform | — |
| PDB entities | 1 |
| Chains and sequence ranges | Author chain D; PDBConstruct 1–103; UniProt 22–124 Author chain E; PDBConstruct 1–103; UniProt 22–124 Author chain F; PDBConstruct 1–103; UniProt 22–124 Author chain G; PDBConstruct 1–103; UniProt 22–124 Author chain H; PDBConstruct 1–103; UniProt 22–124 |